AEGiS-ATDN: Treatment Notes: Drug Resistance Tests Available Through ADAP & Medicaid AIDS Treatment Data NetworkImportant note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu

Treatment Notes: Drug Resistance Tests Available Through ADAP & Medicaid

TREATMENT REVIEW 32 - 33 - Fall/Winter 2000

The New York State ADAP Plus Program has recently added HIV drug resistance testing to the services it covers. Both genotypic and phenotypic drug resistance tests are covered (for more information on these tests, see Treatment Review #31). Medicaid in New York State also now covers these tests. In addition, several new medications, including Kaletra, have been added to the ADAP formulary. For more information contact The Network at (800) 734-7104.
000910
TR000903

Copyright © 2000 - AIDS Treatment Data Network. Reproduction of this article (other than one copy for personal reference) must be cleared through the AIDS Treatment Data Network. Email: .

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .